You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,860,419


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,860,419
Title: Inhalation device
Abstract:An inhalation device is described for use with a medicament pack in which at least one container for medicament in powder form is defined between two sheets peelably secured to one another. The device comprises means for peeling the sheets apart at an opening station to open the container; and an outlet, communicating with the opened container, through which a user can inhale medicament in powder form from the opened container.
Inventor(s): Davies; Michael Birsha (Ware, GB2), Hearne; David John (Luton, GB2), Rand; Paul Kenneth (Letchworth, GB2), Walker; Richard Ian (Ware, GB2)
Assignee: Glaxo Group Limited (London, GB2)
Application Number:08/979,217
Patent Claim Types:
see list of patent claims
Device;
Patent landscape, scope, and claims:

United States Patent 5,860,419: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 5,860,419, titled "Inhalation device," was issued on January 19, 1999. This patent pertains to an inhalation device designed for delivering medicament in the form of a powder. Here, we will delve into the scope and claims of this patent, as well as analyze its position within the broader patent landscape.

Scope of the Patent

The scope of Patent 5,860,419 is defined by its claims, which outline the specific features and functionalities of the inhalation device. Here are the key aspects:

Device Description

The patent describes an inhalation device that allows a user to inhale medicament in the form of a powder. The device is designed to ensure efficient delivery of the medicament directly to the lungs, which is crucial for treating respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD)[2].

Key Components

The device includes several critical components:

  • A housing that contains the medicament in powder form.
  • A mechanism for releasing the powder in a controlled manner.
  • An inhalation chamber where the user inhales the medicament.
  • Optional features such as a dose counter and a breath-activated release mechanism[2].

Claims of the Patent

The claims of the patent are the legal boundaries that define what is protected by the patent. Here are some of the main claims:

Claim 1

Claim 1 is typically the broadest claim and sets the foundation for the rest. For Patent 5,860,419, Claim 1 might describe the overall structure and function of the inhalation device, including the housing, the medicament container, and the inhalation chamber[2].

Subsequent Claims

Subsequent claims usually narrow down the invention by specifying particular features or improvements. These could include specific designs for the powder release mechanism, the material used for the housing, or additional features like a dose counter[2].

Patent Landscape Analysis

To understand the significance and positioning of Patent 5,860,419 within the broader patent landscape, we need to conduct a patent landscape analysis.

Identification of Competitors

Patent landscape analysis helps identify key competitors in the field of inhalation devices. Companies like GlaxoSmithKline, AstraZeneca, and Novartis are prominent players in this sector. By analyzing their patent portfolios, one can determine their strengths, weaknesses, and areas of focus[3].

Technological Trends

The analysis reveals trends in the development of inhalation devices. For instance, there has been a shift towards more sophisticated devices with features like breath-activated release mechanisms and integrated dose counters. This trend indicates a move towards more user-friendly and efficient devices[3].

Market Developments

Market developments such as mergers and acquisitions, licensing agreements, and litigation activities are also crucial. For example, if a major player in the inhalation device market has recently acquired a company with a strong patent portfolio in this area, it could impact the competitive landscape[3].

Patent Expiry and Licensing

Understanding the patent expiry dates is vital for strategic planning. Patents that are about to expire can open up new opportunities for generic or biosimilar products. For Patent 5,860,419, which was issued in 1999, the patent would have expired 20 years later, in 2019, unless extended or renewed[3].

Tools and Resources for Analysis

Several tools and resources are available for conducting a thorough patent landscape analysis:

USPTO Resources

The United States Patent and Trademark Office (USPTO) provides various tools such as the Patent Public Search tool, Global Dossier, and the Patent Examination Data System (PEDS). These resources allow for comprehensive searches and analyses of patent data[1].

International Databases

Databases from other international intellectual property offices like the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) are also essential. These databases provide access to global patent data, enabling a broader analysis[1].

Advanced Analytical Tools

Advanced tools and software are used to categorize and analyze the collected data. These tools help in generating reports with statistical figures, identifying gaps in the market, and highlighting key trends and competitors[3].

Step-by-Step Analysis Process

Define the Scope

Clearly defining the scope of the patent landscape search is critical. This includes determining the regions to search, the time frame, and whether to include abandoned patents[3].

Devise a Search Strategy

Formulating a patent search strategy involves identifying relevant patent and non-patent sources. This includes preliminary searches of patents and technical literature, as well as collaboration with technical and market experts[3].

Categorize the Collections

The collected data is reviewed and categorized by technical and IP expert teams. This step involves manual reading of the collected data to classify the results into accurate and relevant categories[3].

Generate a Report

The final step is generating a comprehensive report that includes statistical graphs and figures. This report provides valuable insights into the patent landscape, helping businesses make informed decisions[3].

Key Takeaways

  • Patent Scope and Claims: Understanding the specific claims and scope of Patent 5,860,419 is essential for determining its legal boundaries and technological contributions.
  • Competitive Landscape: Identifying competitors and their patent portfolios helps in strategizing and positioning within the market.
  • Technological Trends: Analyzing trends in inhalation device technology reveals areas of innovation and potential opportunities.
  • Market Developments: Keeping track of market activities such as mergers, acquisitions, and licensing agreements is crucial for strategic planning.
  • Tools and Resources: Utilizing various tools and databases from the USPTO and international offices facilitates a comprehensive patent landscape analysis.

FAQs

Q: What is the main purpose of Patent 5,860,419?

A: The main purpose of Patent 5,860,419 is to describe an inhalation device designed for delivering medicament in the form of a powder directly to the lungs.

Q: How does patent landscape analysis help businesses?

A: Patent landscape analysis helps businesses identify competitors, understand technological trends, assess market developments, and make informed decisions about research and development and licensing strategies.

Q: What tools are available for conducting a patent landscape analysis?

A: Tools include the USPTO's Patent Public Search, Global Dossier, PEDS, and international databases from offices like the EPO, JPO, and WIPO.

Q: Why is defining the scope of the patent landscape search important?

A: Defining the scope ensures that the search is accurate and precise, helping to avoid irrelevant data and focus on meaningful insights.

Q: What are the key components of a comprehensive patent landscape report?

A: A comprehensive report includes statistical graphs, filing trends, key inventors, top filing countries, and legal status details such as expected expiry dates.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Justia - US Patent for Inhalation device: https://patents.justia.com/patent/5860419
  3. Sagacious Research - Navigating Technological Domains with Patent Landscape Analysis: https://sagaciousresearch.com/blog/navigating-technological-domains-with-patent-landscape-analysis/

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,860,419

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,860,419

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom90 04781.2Mar 02, 1990

International Family Members for US Patent 5,860,419

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 310 ⤷  Subscribe
Austria 401007 ⤷  Subscribe
Austria A43791 ⤷  Subscribe
Australia 5926794 ⤷  Subscribe
Australia 645056 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.